Ratcliffe J, Young T, Buxton M, Eldabi T, Paul R, Burroughs A, Papatheodoridis G, Rolles K
Health Economics Research Group, Brunel University, Uxbridge, UK.
Health Care Manag Sci. 2001 Jun;4(2):117-24. doi: 10.1023/a:1011405610919.
A shortage of donor liver grafts unfortunately results in approximately 10% of patients dying whilst listed for a liver transplant in Europe and the United States. Thus it is imperative that all available organs are used as efficiently as possible. This paper reports upon the application of a simulation modelling approach to assess the impact of several alternative allocation policies upon the cost effectiveness of this technology at one liver transplant centre in the UK. The impact of changes in allocation criteria on the estimated net life expectancy, average net costs and overall cost effectiveness of the transplantation programme were evaluated. The incremental cost effectiveness ratio (ICER) for the base case allocation policy, based upon the time spent on the waiting list (i.e., longest wait first) was 11,557 pounds sterling at 1999 prices. The ICERs associated with an allocation policy based upon age (lowest age first), and an allocation policy based upon the severity of the pre-transplant condition of the patient (with most severely ill patients given a lower priority) were lower than the base case at 10,424 pounds sterling and 9,077 pounds sterling, respectively. The results of this modelling study suggest that the overall cost effectiveness of the liver transplantation programme could be improved if the current allocation policy were modified to give more weight to the age of the patient and the reduced chances of success of the most severely ill patients.
不幸的是,在欧洲和美国,供体肝脏移植物的短缺导致约10%的患者在等待肝脏移植的过程中死亡。因此,必须尽可能高效地利用所有可用器官。本文报告了一种模拟建模方法的应用,以评估几种替代分配政策对英国一家肝脏移植中心这项技术成本效益的影响。评估了分配标准的变化对移植项目估计的净预期寿命、平均净成本和总体成本效益的影响。基于在等待名单上花费的时间(即等待时间最长者优先)的基础案例分配政策的增量成本效益比(ICER),按1999年价格计算为11,557英镑。基于年龄(年龄最小者优先)的分配政策以及基于患者移植前病情严重程度(病情最严重的患者优先级较低)的分配政策的ICER分别低于基础案例,为10,424英镑和9,077英镑。这项建模研究的结果表明,如果修改当前的分配政策,更加重视患者的年龄以及病情最严重患者成功几率降低的情况,肝脏移植项目的总体成本效益可能会得到提高。